Finance

Lists
Why is ANTX up 4.52%?
Dive Deeper
ANTX:NASDAQ
AN2 Therapeutics Inc
$5.32
+4.52%
(+0.23) 1D
$5.30
-0.38% (-0.020)
After hours
Closed: Sep 30, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANTX...
Open
$5.07
High
$5.35
Low
$5.00
Mkt. cap
200.76M
Avg. vol.
231.50K
Volume
199.20K
52-wk high
$7.19
52-wk low
$1.00
EPS
-$1.07
Beta
-0.99
Shares outstanding
37.74M
No. of employees
21
Open
$5.07
High
$5.35
Low
$5.00
Mkt. cap
200.76M
Avg. vol.
231.50K
Volume
199.20K
52-wk high
$7.19
52-wk low
$1.00
EPS
-$1.07
Beta
-0.99
Shares outstanding
37.74M
No. of employees
21
News stories
From web sources and news partners
About AN2 Therapeutics Inc
CEO-
Employees21
Founded2017
HeadquartersMenlo Park, California, United States
SectorPharmaceutical industry
Websitean2therapeutics.com
Analyst ratings
Based on 1 analyst giving stock ratings to ANTX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for ANTX in the last 3 months
Highest
Current $5.32
$9.00 (+69.17%)
Average
$9.00 (+69.17%)
Lowest
$9.00 (+69.17%)
Analyst
Recommendation
Action
Price target
Projected
Date
Bradley Canino
Guggenheim
Buy
Initiated
$9.00
+69.2%
07/19/2026
Joseph Schwartz
Leerink Partners
Buy
Upgraded
$9.00
+69.2%
05/15/2026
Last report
Aug 11, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.18 / -$0.24
+25.00%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7.00M
6.88M
6.74M
6.02M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.04M
2.44M
3.81M
2.88M
Operating expense
10.04M
9.32M
10.55M
8.90M
Total operating expenses
10.04M
9.32M
10.55M
8.90M
Operating income
-10.04M
-9.32M
-10.55M
-8.90M
Other non operating income
-
1.00K
-
-1.00K
EBT including unusual items
-9.35M
-8.71M
-10.03M
-8.18M
EBT excluding unusual items
-9.35M
-8.71M
-10.03M
-8.18M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9.35M
-8.71M
-10.03M
-8.18M
Net profit margin
-
-
-
-
Earnings per share
-0.31
-0.29
-0.29
-0.18
Interest and investment income
687.00K
605.00K
523.00K
720.00K
Interest expense
-
-
-
-
Net interest expenses
687.00K
605.00K
523.00K
720.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps